Press release
Investigation announced for Investors in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) over potential Wrongdoing by certain directors
An investigation on behalf of investors in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) shares.
Investors who purchased shares of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Reviva Pharmaceuticals Holdings officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Cupertino, CA based Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases.
On April 15, 2024, Reviva Pharmaceuticals Holdings, Inc. filed with the SEC a current report on Form 8-K. In this current report, Reviva Pharmaceuticals announced that "the Company's previously issued financial statements for the fiscal year ended December 31, 2022 included in its Annual Report on Form 10-K, the interim financial statements for the quarterly period ended September 30, 2022 included in its Quarterly Report on Form 10-Q, and each of the interim financial statements for the quarterly periods in fiscal 2023 included in its Quarterly Reports on Form 10-Q (cumulatively, the "Restatement Periods") should be restated to correct historical errors related principally to the timing of recognition of the Company's estimated accrual of certain research and development expenses, and should therefore no longer be relied upon."
Shares of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) declined from over $8 per share in May 2023 to as low as $1.60 per share on May 15, 2024.
Those who purchased shares of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) over potential Wrongdoing by certain directors here
News-ID: 3560791 • Views: …
More Releases from Shareholders Foundation, Inc.
Lawsuit filed for Investors who lost money with shares of Primo Brands Corporati …
An investor, who purchased shares of Primo Brands Corporation (NYSE: PRMB), filed a lawsuit over alleged violations of Federal Securities Laws in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of Primo Water (formerly NYSE: PRMW) between June 17, 2024 through November 8, 2024, and/or purchased a significant amount of shares Primo Brands Corporation (NYSE: PRMB) between November 11, 2024 through November 6,…
Lawsuit Alert: Investors who lost a substantial amount with Telix Pharmaceutical …
An investor, who purchased shares of Telix Pharmaceuticals Limited (NASDAQ: TLX), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by Telix Pharmaceuticals Limited in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Telix Pharmaceuticals Limited (NASDAQ: TLX) have certain options and for certain investors are short and strict deadlines running. Deadline: January 9, 2026. NASDAQ: TLX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in shares of Savara Inc. (NASDAQ …
An investigation was announced for long-term investors in shares of Savara Inc. (NASDAQ: SVRA) concerning potential breaches of fiduciary duties by certain directors of Savara Inc.
Investors who are current long term investors in Savara Inc. (NASDAQ: SVRA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: SVRA stocks…
Lawsuit filed for Investors who lost money with shares of Inspire Medical System …
An investor, who purchased shares of Inspire Medical Systems, Inc. (NYSE: INSP), filed a lawsuit over alleged violations of Federal Securities Laws by Inspire Medical Systems, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Inspire Medical Systems, Inc. (NYSE: INSP) have certain options and for certain investors are short and strict deadlines running. Deadline: January 5, 2026. NYSE: INSP investors should contact the Shareholders…
More Releases for Reviva
Schizophrenia Market Expected to rise, 2034 | Boehringer Ingelheim, Karuna Thera …
The Schizophrenia market growth is driven by factors like increase in the prevalence of Schizophrenia, investments in research and development, entry of emerging therapies during the study period 2020-2034.
The Schizophrenia market report [https://www.delveinsight.com/report-store/schizophrenia-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr] also offers comprehensive insights into the Schizophrenia market size, share, Schizophrenia epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration in the space, market uptake by key therapies and companies actively pushing Schizophrenia market…
Schizophrenia Market Is Expected to Showcase a Significant Growth During the For …
Recent research indicates that long-acting injectables (LAIs) may be more effective than oral medications in reducing the risk of hospitalization for schizophrenia. Injectables like ARISTADA|ARISTADA INITIO (aripiprazole lauroxil), ABILIFY MAINTENA (aripiprazole), INVEGA PRODUCTS, RISPERDAL CONSTA (risperidone), PERSERIS (risperidone), and other injectables play a significant role in this domain.
According to DelveInsight, the Schizophrenia Market is projected to expand in the forthcoming years due to the growing prevalence of schizophrenia patients in…
Skin Care Peels Market Growing Popularity and Emerging Trends | Reviva Labs, Ski …
The latest study released on the Global Skin Care Peels Market by AMA Research evaluates market size, trend, and forecast to 2030. The Skin Care Peels market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.…
Depression-MDD Drugs Market: Reviva Pharmaceuticals Holdings, H. Lundbeck, Glaxo …
The Depression-MDD Drugs Market research report offers in-depth information to acknowledge the imperative parts of the market that align demand, raw materials, and capacity; this helps make strategic decisions. In addition, the analysis provides demands for the future, besides the available opportunities for an individual. The study focuses on industry chain analysis, upstream and downstream raw material suppliers, key players, production process analysis, cost analysis, market distribution channels, and major…
Global Skin Care Peels Market Analysis 2020 Reviva Labs, Bliss, SkinCeuticals, N …
Global Skin Care Peels market represents the advanced technology manufacturer with high quality data such as segment wise data, region wise data and qualitative analysis of the data which is collected from industry expert and market participants across the key points of market value chain. The market report is also comes up with the comprehensive study of Skin Care Peels market insight, historical data from 2015-2019, forecast data from 2020-2025,…
Business Opportunities in Skin Care Masks Market - Key Drivers, Olay, Estee Laud …
This Global Skin Care Masks report 2024 focus on global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from global and major regions such as Europe, North America, China, Japan, Southeast Asia and etc. Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export and etc. Industry chain, manufacturing…
